A devastating medical error at Saitama Children's Medical Center has resulted in one death and left two patients in critical condition after they received contaminated anticancer drug injections in 2025, according to reports from NHK and other Japanese media outlets. The incident occurred at the prefectural hospital located in Chuo Ward, Saitama City, when three leukemia patients received injections of anticancer medication. Following the treatment, all three patients developed severe neurological symptoms including difficulty walking. One teenage male patient subsequently died, while the remaining two patients remain in critical condition and are currently undergoing treatment. According to NHK, an investigation committee established to examine the incident has concluded that the most likely cause was contamination of the anticancer drug with another medication. The hospital has reported the case to police as both a potential criminal matter and accident, acknowledging the severity of the error and its consequences. The Saitama Children's Medical Center is a major pediatric facility serving the greater Tokyo metropolitan area, including many international families residing in Saitama Prefecture. The hospital specializes in treating serious childhood illnesses, including cancer, making it a crucial healthcare resource for families with children requiring specialized care. For foreign residents in Japan, this incident highlights critical concerns about medical safety protocols, even at major specialized hospitals. While Japan's healthcare system generally maintains high standards, this case demonstrates that serious errors can occur, particularly in complex treatment scenarios involving potent medications like chemotherapy drugs. The investigation's findings suggest a breakdown in medication preparation or administration protocols. Anticancer drugs require extremely careful handling, preparation, and verification before administration due to their potent nature and narrow therapeutic margins. The mixing of different medications could result from errors in drug preparation, labeling, or verification procedures—all of which should involve multiple safety checks. In response to the tragedy, hospital administrators have pledged to strengthen their management systems and implement measures to prevent recurrence. However, specific details about what procedural changes will be implemented have not yet been publicly disclosed. For expat families using Japanese healthcare facilities, this incident serves as a reminder of the importance of being informed and engaged in medical treatment, especially for serious conditions. While language barriers can make this challenging, families should consider: Asking questions about medication administration procedures, even if requiring translation assistance. Most major hospitals have interpretation services available, and it is entirely appropriate to request clarification about treatments, particularly for serious conditions like cancer. Requesting written information about medications being administered. This can be reviewed with bilingual friends, translation apps, or interpretation services to ensure understanding. Considering second opinions for serious diagnoses and treatment plans, which is a common and accepted practice in Japanese medicine. The hospital's decision to involve police indicates the institution is taking the matter seriously and acknowledging potential criminal liability. In Japan, medical errors resulting in death can lead to professional discipline, civil liability, and in cases of gross negligence, criminal prosecution. As this case develops, affected families may pursue compensation through Japan's medical malpractice system, which typically involves lengthy litigation or mediation processes. Foreign residents should be aware that legal proceedings in Japan can be time-consuming and may require specialized legal assistance, particularly for non-Japanese speakers. This tragic incident underscores the need for continued vigilance in medical safety protocols and the importance of transparent communication between healthcare providers and patients, regardless of language or cultural background. The hospital has not announced when its investigation findings and preventive measures will be fully disclosed to the public.